Research Analysts Offer Predictions for Denali Therapeutics Inc.'s Q3 2024 Earnings (NASDAQ:DNLI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics Inc. Forecasted to Post Q3 2024 Earnings of ($0.58) Per Share (NASDAQ:DNLI) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.05), Briefing.com reports. Denali Therapeutics had a negative return on equity of 11.54% and a negative net margin of 36.51%. During the same […]